| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments of acquisition related contingent consideration and consideration holdback | 6,800 | - |
| Taxes paid for shares withheld under employee equity plans, net of proceeds from issuance of class a common stock | -4,608 | -4,719 |
| Net cash (used in) provided by financing activities | -14,683 | -6,434 |
| Effects of exchange rate changes on cash and cash equivalents | -46 | -38 |
| Net (decrease) increase in cash and cash equivalents | -78,825 | -52,492 |
| Cash and cash equivalents at beginning of period | 322,399 | - |
| Cash and cash equivalents at end of period | 243,574 | - |
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)